Neoadjuvant sintilimab combined with chemotherapy in resectable locally advanced non-small cell lung cancer: case series and literature review.

World J Surg Oncol · 2023 · PMC10521519 · PMID 37749594

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an interesting trendno p-value reported

However, an interesting trend has emerged in recent years regarding the shifting landscape of immunotherapy trials.

also in 497 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.